Breathing space for MA

Authorisation of the 17th edition expires on 11 January 2015, but contention about a clause in the proposed 18th edition — which the ACCC reviewed some months ago — has delayed its authorisation. 

In edition 18, Medicines Australia proposed a new reporting regime that required reporting of “transfers of value” — such as speaking fees, advisory board fees or sponsorship to attend a conference — subject to the consent of the healthcare